Aurora Cannabis (ACB) Change in Accured Expenses (2018 - 2019)
Aurora Cannabis (ACB) reported Change in Accured Expenses of -$16.6 million for Q1 2019, down 3.8% quarter-over-quarter from -$16.0 million in Q4 2018.
Aurora Cannabis (ACB) Change in Accured Expenses (2018 - 2019) Analysis & Trends
Aurora Cannabis (ACB) has 2 years of Change in Accured Expenses data on file, last reported at -$16.6 million in Q1 2019.
- Change in Accured Expenses for Q1 2019 came in at -$16.6 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2019 was -$16.6 million (changed N/A YoY), and the FY2018 annual result was -$20.2 million, changed N/A from the prior year.
- Change in Accured Expenses slipped to -$16.6 million in Q1 2019 per ACB's latest filing, from -$16.0 million in the prior quarter.
- Over five years, Change in Accured Expenses peaked at -$16.0 million in Q4 2018 and troughed at -$20.2 million in Q2 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accured Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -144.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | -234.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -12.70 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | -14.30 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 4.89 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 23.00 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 10.02 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 14.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2019 | -16.58 Mn |
| Mar 31, 2019 | -16.58 Mn |
| Dec 31, 2018 | -15.97 Mn |
| Dec 31, 2018 | -15.97 Mn |
| Jun 30, 2018 | -20.25 Mn |
| Jun 30, 2018 | -20.25 Mn |